Peters M J, Tasker R C, Kiff K M, Yates R, Hatch D J
Department of Paediatric Intensive Care, Great Ormond Street Hospital for Children, London, UK.
Intensive Care Med. 1998 Jul;24(7):699-705. doi: 10.1007/s001340050647.
Acute hypoxemic respiratory failure (AHRF) is a common reason for emergency pediatric intensive care. An objective assessment of disease severity from acute physiological parameters would be of value in clinical practice and in the design of clinical trials. We hypothesised that there was a difference in the best early respiratory indices in those who died compared with those who survived.
A prospective observational study of 118 consecutive AHRF admissions with data analysis incorporating all blood gases.
A pediatric intensive care unit in a national children's hospital.
None.
Mortality was 26/118, 22% (95 % confidence interval 18-26%). There were no significant differences in the best alveolar-arterial oxygen tension gradient (A-aDO2, torr), oxygenation index (OI), ventilation index (VI), or PaO2/FIO2 during the first 2 days of intensive care between the survivors and non-survivors. Only the mean airway pressure (MAP, cm H2O) used for supportive care was significantly different on days 0 and 1 (p < 0.05) with higher pressure being used in non-survivors. Multiple logistic regression analysis did not identify any gas exchange or ventilator parameter independently associated with mortality. Rather, all deaths were associated with coincident pathology or multi-organ system failure, or perceived treatment futility due to pre-existing diagnoses instead of unsupportable respiratory failure. When using previously published predictors of outcome (VI > 40 and OI > 40; A-aDO2 > 450 for 24 h; A-aDO2 > 470 or MAP > 23; or A-aDO2 > 420) the risk of mortality was overestimated significantly in the current population.
The original hypothesis was refuted. It appears that the outcome of AHRF in present day pediatric critical care is principally related to the severity of associated pathology and now no longer solely to the severity of respiratory failure. Further studies in larger series are needed to confirm these findings.
急性低氧性呼吸衰竭(AHRF)是儿科重症监护病房常见的急诊病因。通过急性生理参数对疾病严重程度进行客观评估,在临床实践和临床试验设计中均具有重要价值。我们推测,死亡患儿与存活患儿的最佳早期呼吸指标存在差异。
一项对118例连续收治的AHRF患儿进行的前瞻性观察研究,并对所有血气数据进行分析。
一家国立儿童医院的儿科重症监护病房。
无。
死亡率为26/118,即22%(95%置信区间18 - 26%)。在重症监护的头2天,存活者与非存活者之间的最佳肺泡 - 动脉氧分压差(A-aDO2,托)、氧合指数(OI)、通气指数(VI)或PaO2/FIO2均无显著差异。仅用于支持治疗的平均气道压(MAP,厘米水柱)在第0天和第1天存在显著差异(p < 0.05),非存活者使用的压力更高。多因素逻辑回归分析未发现任何与死亡率独立相关的气体交换或呼吸机参数。相反,所有死亡均与合并症、多器官系统功能衰竭或因既往诊断导致的治疗无效有关,而非不可支持的呼吸衰竭。当使用先前发表的预后预测指标(VI > 40且OI > 40;A-aDO2 > 450持续24小时;A-aDO2 > 470或MAP > 23;或A-aDO2 > 420)时,当前人群的死亡风险被显著高估。
原假设被推翻。如今儿科重症监护中AHRF的预后似乎主要与相关合并症的严重程度有关,而不再仅仅取决于呼吸衰竭的严重程度。需要进一步开展更大规模的系列研究以证实这些发现。